Authors: | Sands, J.; Tolaney, S. M.; Ueno, N. T.; Spira, A. I.; Yamamoto, N.; Janjigian, Y. Y.; Naito, Y.; Damodaran, S.; Meric-Bernstam, F.; Modi, S.; Enzinger, P. C.; Mohapatra, A. S.; Iko, Y.; He, S.; Nakajima, K.; Shitara, K. |
Abstract Title: | A phase 1b, multicenter, open-label study of valemetostat in combination with DXd antibody drug conjugates (ADCs), trastuzumab deruxtecan (T-DXd) or datopotamab deruxtecan (Dato-DXd), in patients with solid tumors |
Meeting Title: | 2024 ASCO Annual Meeting |
Journal Title: | Journal of Clinical Oncology |
Volume: | 42 |
Issue: | 16 Suppl. |
Meeting Dates: | 2024 May 31-Jun 4 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2024-06-01 |
Language: | English |
ACCESSION: | WOS:001275557406175 |
PROVIDER: | wos |
DOI: | 10.1200/JCO.2024.42.16_suppl.TPS4180 |
Notes: | Meeting Abstract: TPS4180 -- Source: Wos |